-

Taro to Announce Full Year Results on May 19, 2020

Earnings Call to be Conducted Wednesday, May 20 at 8:00 am ET

HAWTHORNE, N.Y.--(BUSINESS WIRE)--Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced today that it plans to release its financial results for year ended March 31, 2020, on Tuesday, May 19, 2020.

The Company will conduct an earnings call at 8:00 am ET on Wednesday, May 20, 2020, where senior management will discuss the Company’s performance and answer questions from participants.

The release will be accessible on Taro’s website at www.taro.com.

Earnings Call (8:00 am ET on Wednesday, May 20, 2020)

To participate in this conference call, please dial the numbers provided below five to ten minutes ahead of the scheduled start time. The operator will provide instructions on asking questions before the call. You can also hear the call via an audio webcast, details of which will be announced later on the Company website, www.taro.com. A transcript of this earnings call will also be available on the website.

Summary of events

Event

Date and time

Telephone number / website

Earnings release

May 19, 2020 (AMC)

www.taro.com

Earnings conference call

May 20, 2020
8:00 am ET

Participant Toll-Free Dial-In Number: +1 (844) 421-0601
Participant International Dial-In Number: +1 (716) 247-5800
ID: 5275616

Via audio webcast, details of which will be made available on www.taro.com.

Replay of conference call

May 20, 2020 to
May 27, 2020

+1 (855) 859-2056 or +1 (404) 537-3406
ID: 5275616

Via audio webcast playback, details of which will be made available on www.taro.com.

About Taro
Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit the Company’s website at www.taro.com.

Contacts

Daphne Huang
VP, CFO
(914) 345-9001
Daphne.Huang@taro.com

William J. Coote
AVP, Business Finance, Treasurer and Investor Relations
(914) 345-9001
William.Coote@taro.com

Taro Pharmaceutical Industries Ltd.

NYSE:TARO

Release Summary
Taro to Announce Results for Year Ended March 31, 2020
Release Versions

Contacts

Daphne Huang
VP, CFO
(914) 345-9001
Daphne.Huang@taro.com

William J. Coote
AVP, Business Finance, Treasurer and Investor Relations
(914) 345-9001
William.Coote@taro.com

More News From Taro Pharmaceutical Industries Ltd.

Taro Provides Results for Year Ended March 31, 2024

HAWTHORNE, N.Y.--(BUSINESS WIRE)--TARO PROVIDES RESULTS FOR YEAR ENDED MARCH 31, 2024...

Taro to Release Full Year Results on May 20, 2024

HAWTHORNE, N.Y.--(BUSINESS WIRE)--TARO TO RELEASE FULL YEAR RESULTS ON MAY 20, 2024...

Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Taro Shareholders Vote “FOR” Taro Sun Pharma Merger

NEW YORK--(BUSINESS WIRE)--Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Taro Shareholders Vote “FOR” Taro Sun Pharma Merger...
Back to Newsroom